9105 - 006 * 
9105 - 007 * 
9105-008 
9105 - 009 * 
9110 - 010 * 
9110-011 
(M) Brenner, Malcolm K.; Mirro, Joseph; Santana, Victor; and Ihle, James, 
St. Jude Children's Research Hospital; A Phase II Trial of High-Dose 
Carboplatin and Etoposide with Autologous Marrow Support for 
Treatment of Relapse/Refractory Neuroblastoma Without Apparent Bone 
Marrow Involvement. 
Date of RAC Approval: 5-31-91 
Date of NIH Approval: 7-12-91 
Minor Modification: 11-91 
(M) Deisseroth, Albert B., M.D. Anderson Cancer Center; Autologous Bone 
Marrow Transplantation for Chronic Myelogenous Leukemia in which 
Retroviral Markers are Used to Discriminate between Relapse which Arises 
from Systemic Disease Remaining after Preparative Therapy Versus 
Relapse due to Residual Leukemic Cells in Autologous Marrow: A Pilot 
Trial. 
Date of RAC Approval: 5-31-91 
Date of NIH Approval: 7-12-91 
Minor Modification: 4-19-93 
(M) Ledley, Fred D.; Woo, Savio; Ferry, George; and Hartwell, 
Whigennand, Baylor College of Medicine; Hepatocellular 
Transplantation in Acute Hepatic Failure and Targeting Genetic Markers 
to Hepatic Cells. 
Date of RAC Approval: 5-30-91 
Date of NIH Approval: 7-12-91 
(M) Lotze, Michael T., University of Pittsburgh School of Medicine; The 
Administration of Interleukin-2 and Tumor Infiltrating Lymphocytes to 
Patients with Melanoma. 
Date of RAC Approval: 5-30-91 
Date of NIH Approval: 1-17-92 
Minor Modification: 11-30-92 
(T) Rosenberg, Steven A, National Cancer Institute; Immunization of 
Cancer Patients Using Autologous Cancer Cells Modified by Insertion of 
the Gene for Tumor Necrosis Factor (TNF). 
Date of RAC Approval: 10-7-91 
Date of NIH Approval: 10-15-91 
Minor Modification: 7-9-92 
(T) Rosenberg, Steven A, National Cancer Institute; Immunization of 
Cancer Patients Using Autologous Cancer Cells Modified by Insertion of 
the Gene for Interleukin- 2 (IL-2). 
Date of RAC Approval: 10-7-91 
Date of NIH Approval: 10-15-91 
Recombinant DNA Research, Volume 18 
[229] 
